SCHEMBL20038047

SCHEMBL20038047

CCN(C(=O)C(C)(C)C)c1ccc(C)nc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.42
MEN1 O00255 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MLYCD O95822 1/20 0.42
OXTR P30559 7/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.37
CNR2 P34972 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
AVPR1A P37288 1/20 0.36
ATM Q13315 1/20 0.36
HTT P42858 1/20 0.35
AVPR2 P30518 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GLA P06280 1/20 0.35
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7731822 0.81 MEN1 (0.60) KMT2AMEN1CYP3A4CYP2C9CYP2C19
SCHEMBL3634800 0.81 MLYCD (0.40) KMT2AMLYCDOXTRMAPTHDAC1
SCHEMBL16454352 0.79 HDAC1 (0.39) KMT2AMEN1CYP3A4CYP2C9CYP2C19
SCHEMBL17333657 0.73 MEN1 (0.76) KMT2AMEN1CYP3A4CYP2C9CYP2C19
SCHEMBL20037880 0.72 TP53 (0.38) KMT2ASMN1; SMN2MLYCDMAPTHDAC1
SCHEMBL10566572 0.71 MEN1 (0.49) KMT2AMEN1CYP3A4CYP2C9CYP2C19
SCHEMBL8915053 0.71 MEN1 (0.46) KMT2AMEN1CYP3A4CYP2C9CYP2C19
SCHEMBL13942706 0.70 ALDH1A1 (0.45) KMT2AMEN1CYP3A4SMN1; SMN2MAPT
SCHEMBL2241922 0.69 HDAC1 (0.42) KMT2ASMN1; SMN2POLBMAPTHDAC1
SCHEMBL20038435 0.69 MLYCD (0.37) CYP3A4CYP2C9CYP2C19MLYCDOXTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3305785-A1 PYRIDO[3,4-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Teijin Pharma Limited (JP) 2018-04-11 EP disclosed